Adalimumab in Axial Spondyloarthritis. An Investigation of Whole-body MRI, MRI of Sacroiliac Joints and Spine and Soluble Biomarkers of Joint Inflammation and Damage.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Spondylarthritis
- Focus Therapeutic Use
- Acronyms ASIM
- 17 Jun 2017 Results (n=21) of US substudy, presented at the 18th Annual Congress of the European League Against Rheumatism
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
- 21 Aug 2015 Last checked against ClinicalTrials.gov record.